CT Tumor Volume Measurement in Advanced Non-small-cell Lung Cancer
- 1 November 2010
- journal article
- research article
- Published by Elsevier BV in Academic Radiology
- Vol. 18 (1), 54-62
- https://doi.org/10.1016/j.acra.2010.08.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung CancerRadiology, 2009
- Pulmonary Nodules: Volume Repeatability at Multidetector CT Lung Cancer ScreeningRadiology, 2009
- Noncalcified Lung Nodules: Volumetric Assessment with Thoracic CTRadiology, 2009
- Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- CT Evaluation of the Response of Gastrointestinal Stromal Tumors After Imatinib Mesylate Treatment: A Quantitative Analysis Correlated with FDG PET FindingsAmerican Journal of Roentgenology, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986